Press Releases

All Releases
View Summary Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 4, 2016
PDF 12.6 KB Add to Briefcase
View Summary Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan
Nov 30, 2015
PDF 115.4 KB Add to Briefcase
View Summary Ironwood Reports Positive Top-Line Data from Phase II Trial of Linaclotide in Adult Patients With Opioid-Induced Constipation
Nov 30, 2015
PDF 157.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Credit Suisse 24th Annual Healthcare Conference
Nov 4, 2015
PDF 15.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Third Quarter 2015 Investor Update
Nov 3, 2015
PDF 187.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701
Nov 3, 2015
PDF 19.4 KB Add to Briefcase
View Summary Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation
Nov 2, 2015
PDF 160.8 KB Add to Briefcase
View Summary Allergan Acquires Rights To Ironwood's CONSTELLA® (Linaclotide) From Almirall In More Than 40 Countries
Oct 27, 2015
PDF 23.4 KB Add to Briefcase
View Summary Ironwood Highlights Refractory GERD and Constipation Research at the American College of Gastroenterology 2015 Annual Scientific Meeting
Oct 19, 2015
PDF 158.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Third Quarter 2015 Investor Update Call
Oct 14, 2015
PDF 15.9 KB Add to Briefcase
View Summary Ironwood Reports Positive Top-Line Results from Phase III Trial of 72 mcg Linaclotide in Adults with Chronic Idiopathic Constipation
Oct 13, 2015
PDF 157.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Sep 10, 2015
PDF 15.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update
Aug 5, 2015
PDF 180.3 KB Add to Briefcase
View Summary Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.
Aug 5, 2015
PDF 164.7 KB Add to Briefcase
View Summary Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973
Jul 22, 2015
PDF 19.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Second Quarter 2015 Investor Update Call
Jul 15, 2015
PDF 15.9 KB Add to Briefcase
View Summary AstraZeneca and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Designed to Support Linaclotide Approval in China
Jul 8, 2015
PDF 116.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Prices $300 Million of Convertible Senior Notes
Jun 10, 2015
PDF 110.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Proposed Offering of $300 Million of Convertible Senior Notes
Jun 8, 2015
PDF 109.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Goldman Sachs 36th Annual Global Healthcare Conference
Jun 4, 2015
PDF 15.6 KB Add to Briefcase
Showing 61-80 of 237 Page: 1 2 3 4 5 6 7 8 ... 12  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.